Oral chemotherapeutic agents in elderly acute myeloid leukemia (AML) patients, a study from a developing country

被引：0
|
作者：
Mukhopadhyay, S. [1 ]
Chitalkar, P. [1 ]
Gupta, P. [1 ]
Roy, U. [1 ]
Mukhopadhyay, A. [1 ]
机构：
[1] Netaji Subhash Chandra Bose Canc Res Inst, Kolkata, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7057
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nivolumab (Nivo) with Azacytidine (AZA) in Patients (pts) with Relapsed Acute Myeloid Leukemia (AML) or Frontline Elderly AML
    Daver, Naval
    Garcia-Manero, Guillermo
    Basu, Sreyashi
    Cortes, Jorge E.
    Ravandi, Farhad
    Jabbour, Elias J.
    Assi, Rita
    Brandt, Mark
    Pierce, Sherry
    Gordon, Tauna
    Pemmaraju, Naveen
    Andreeff, Michael
    Ning, Jing
    Kornblau, Steven
    Kadia, Tapan
    Flores, Wilmer
    Matthews, Jairo
    DiNardo, Courtney D.
    Borthakur, Gautam
    Konopleva, Marina
    Allison, James
    Sharma, Padmanee
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
  • [32] Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study
    Ashley Leak Bryant
    Thomas W. LeBlanc
    Tara Albrecht
    Ya-Ning Chan
    Jaime Richardson
    Matthew Foster
    Malisa Dang
    William Dudley
    Susie Owenby
    Debra Wujcik
    Supportive Care in Cancer, 2020, 28 : 5157 - 5164
  • [33] Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study
    Bryant, Ashley Leak
    LeBlanc, Thomas W.
    Albrecht, Tara
    Chan, Ya-Ning
    Richardson, Jaime
    Foster, Matthew
    Dang, Malisa
    Dudley, William
    Owenby, Susie
    Wujcik, Debra
    SUPPORTIVE CARE IN CANCER, 2020, 28 (11) : 5157 - 5164
  • [34] Ambulatory treatment of acute myeloid leukemia (AML) with weekly oral idarubicin alone in poor-risk elderly patients.
    Anglaret, B
    Belhabri, A
    Chelghoum, Y
    Renaudier, P
    Troncy, J
    Bouheddou, N
    Peaud, PY
    Chevalier, MP
    Thomas, X
    BLOOD, 2000, 96 (11) : 208B - 208B
  • [35] Acute Myeloid Leukemia: Incremental Improvement in Outcome in a Developing Country
    Peyam, S.
    Trehan, A.
    Jain, R.
    Bansal, D.
    Varma, N.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S186 - S186
  • [36] CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA: A DEVELOPING COUNTRY EXPERIENCE
    Mohammed, R.
    Yadav, S. P.
    Meena, L.
    Verma, I. C.
    Sachdeva, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 228 - 228
  • [37] Management of Acute Myeloid Leukemia (AML) in Older Patients
    Maya Abdallah
    Zhuoer Xie
    Audrey Ready
    Dharmini Manogna
    Jason H. Mendler
    Kah Poh Loh
    Current Oncology Reports, 2020, 22
  • [38] Management of Acute Myeloid Leukemia (AML) in Older Patients
    Abdallah, Maya
    Xie, Zhuoer
    Ready, Audrey
    Manogna, Dharmini
    Mendler, Jason H.
    Loh, Kah Poh
    CURRENT ONCOLOGY REPORTS, 2020, 22 (10)
  • [39] Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients
    Staib, P
    Lathan, B
    Knoppel-Schwark, S
    Tesch, H
    Voliotis, D
    Steinmetz, HT
    Schwonzen, M
    Wickramanayake, PD
    Diehl, V
    ANNALS OF ONCOLOGY, 1998, 9 (02) : 221 - 223
  • [40] Analysis of 210 febrile neutropenic episodes during induction therapy of acute myeloid leukemia (AML): An institutional experience from a developing country
    Konatam, M. L.
    Rajappa, S.
    Digumarti, R.
    Maddali, L. S.
    Vemu, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345